pirenzepine and eye
pirenzepine has been researched along with eye in 8 studies
Research
Studies (8)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors
Authors | Studies |
---|---|
Laties, AM; Lin, T; Stone, RA | 1 |
Cynader, MS; Drance, SM; Gupta, N; McAllister, R; Rootman, J | 1 |
Cottriall, CL; McBrien, NA | 1 |
Fernandes, A; Iuvone, PM; Laties, AM; Mallorga, PJ; Stone, RA; Sugrue, MF; Tigges, M | 1 |
Cheng, NN; Chu, RY; Le, QH; Wu, W | 1 |
McBrien, NA; Metlapally, S | 1 |
Jordan, K; Nickla, DL; Singh, P; Yang, J | 1 |
Ashby, R; Hardy, K; Karouta, C; Kucharski, R; Maleszka, R; Morgan, I; Thomson, K | 1 |
Other Studies
8 other study(ies) available for pirenzepine and eye
Article | Year |
---|---|
Muscarinic antagonist effects on experimental chick myopia.
Topics: Animals; Chick Embryo; Eye; Myopia; Pirenzepine; Receptors, Muscarinic; Retina | 1991 |
Muscarinic receptor M1 and M2 subtypes in the human eye: QNB, pirenzipine, oxotremorine, and AFDX-116 in vitro autoradiography.
Topics: Adult; Aged; Aged, 80 and over; Anterior Eye Segment; Autoradiography; Ciliary Body; Eye; Female; Humans; Iris; Male; Middle Aged; Oxotremorine; Parasympatholytics; Pirenzepine; Quinuclidinyl Benzilate; Receptors, Muscarinic; Retina | 1994 |
The M1 muscarinic antagonist pirenzepine reduces myopia and eye enlargement in the tree shrew.
Topics: Accommodation, Ocular; Animals; Conjunctiva; Disease Models, Animal; Eye; Hypertrophy; Injections; Muscarinic Antagonists; Myopia; Pirenzepine; Refraction, Ocular; Retina; Sclera; Sensory Deprivation; Tupaiidae | 1996 |
Effects of muscarinic cholinergic receptor antagonists on postnatal eye growth of rhesus monkeys.
Topics: Animals; Animals, Newborn; Atropine; Drug Therapy, Combination; Eye; Macaca mulatta; Muscarinic Antagonists; Myopia; Ophthalmic Solutions; Pirenzepine; Precipitin Tests; Rabbits; Receptors, Muscarinic; Refraction, Ocular; Sensory Deprivation; Treatment Outcome | 1999 |
Effect of pirenzepine ophthalmic solution on form-deprivation myopia in the guinea pigs.
Topics: Animals; Eye; Guinea Pigs; Muscarinic Antagonists; Myopia; Ophthalmic Solutions; Organ Size; Pirenzepine; Refraction, Ocular | 2005 |
The effect of pirenzepine on positive- and negative-lens-induced refractive error and ocular growth in chicks.
Topics: Animals; Animals, Newborn; Biometry; Chickens; Contact Lenses; Disease Models, Animal; Eye; Glycosaminoglycans; Hyperopia; Intravitreal Injections; Muscarinic Antagonists; Myopia; Pirenzepine; Sclera; Sensory Deprivation | 2010 |
Effects of time-of-day on inhibition of lens-induced myopia by quinpirole, pirenzepine and atropine in chicks.
Topics: Animals; Animals, Newborn; Atropine; Chickens; Circadian Rhythm; Dopamine Agonists; Drug Administration Schedule; Eye; Intravitreal Injections; Muscarinic Antagonists; Myopia; Pirenzepine; Quinpirole; Sensory Deprivation | 2019 |
Transcriptome-based insights into gene networks controlling myopia prevention.
Topics: Alternative Splicing; Animals; Atropine; Chickens; Circadian Rhythm; Early Growth Response Protein 1; Eye; Gene Expression Regulation; Gene Regulatory Networks; Humans; Janus Kinases; Male; Models, Biological; Myopia; Phosphinic Acids; Pirenzepine; Pyridines; Reproducibility of Results; Retina; STAT Transcription Factors; Tetrahydronaphthalenes; Time Factors; Transcriptome | 2021 |